Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
A Phase 1 Trial of 2 Dose Schedules of ABT-510, an Antiangiogenic, Thrombospondin-1-mimetic Peptide, in Patients With Advanced Cancer Gordon, Michael S.; Mendelson, David; Carr, Robert; Knight, Raymond A.; Humerickhouse, Rod A.; Iannone, Maria; Stopeck, Alison T. Share Save
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors Gietema, J. A.; Hoekstra, R.; de Vos, F. Y. F. L.; Uges, D. R. A.; van der Gaast, A.; Groen, H. J. M.; Loos, W. J.; Knight, R. A.; Carr, R. A.; Humerickhouse, R. A.; Eskens, F. A. L. M. Share Save